Dr. Sofie Buyse · Checked.be

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of Dr. Sofie Buyse is 0.2% (very low). The 2024 annual accounts show equity of €72k and a net result of €32k. Its solvency ranks better than 23% of 6584 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 2 annual accounts.

Signals

2 signals · with evidence

Weak solvency vs sector

Solvency (equity / total assets) is in the sector's weakest quartile: better than 23% of 6584 sector peers (2024).

View the sector comparison

Consistently profitable

Positive net result in the two most recent financial years (2023 and 2024).

View the result trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide

Deadline passed, not yet counted as missing

The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 20 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.

Latest accounts filed on time

The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 10-07-2025, 21 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.

How we compute the deadline

The year end is derived from 2 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.

Deadline per financial year

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	10-07-2025	21 d early	2025-00252149
31-12-2023	31-07-2024	26-06-2024	35 d early	2024-00169076

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals

More than 3 years active

Founded in 2023, past the statistically most fragile first 3 years.

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone

0.2% Very low

0%0,5%1,5%4%10%≥25%

Lower-failure-rate sector −Young company +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)

EBIT marginNot published (abbreviated filing)

Net result€32k-10.1%

Working capital€-26k+55.8%

CSV export

Annual accounts & ratios

Source: NBB · 2024

Annual accounts filed on 10-07-2025 with the NBB · fiscal year 2024 · micro

Operating resultNet result

Sector comparison

Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (micro schema)

Metric	This company	Sector median	Position in the sector
Solvency	30.4%	66.7%	better than 23% of 6584 sector peers
Net result	€32k	€46k	better than 39% of 6578 sector peers
Equity	€72k	€79k	better than 47% of 6584 sector peers
Gross operating margin	€71k	€78k	better than 46% of 6586 sector peers
Total assets	€235k	€154k	better than 66% of 6587 sector peers

Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.

EBITDA

€70k

+4.0% 23-24

Net profit

€32k

-10.1% 23-24

Cash flow

€55k

+6.5% 23-24

Total assets

€235k

-26.3% 23-24

Equity

€72k

+81.9% 23-24

Working capital

€-26k

+55.8% 23-24

Income taxes

€9k

-30.6% 23-24

Debt

€164k

-41.5% 23-24

Show 9 other metrics

Debt ≤ 1y

€53k

-64.8% 23-24

Debt > 1y

€109k

-16.2% 23-24

Current ratio

0.50

-16.7% 23-24

Quick ratio

0.50

-16.7% 23-24

Solvency

30.4%

+146.6% 23-24

Debt / equity

2.29

-67.8% 23-24

ROE

45.0%

-50.6% 23-24

ROA

13.7%

+21.9% 23-24

Interest coverage

11.54

-54.3% 23-24

Figures by fiscal year

Highlight YoY changes (±10%)

Fiscal year	2024
Deposit	micro
Revenue	-
EBITDA	€70k
Net profit	€32k
Cash flow	€55k
Staff costs	-
Income taxes	€9k
Dividends	-
Total assets	€235k
Equity	€72k
Debt	€164k
of which ≤ 1y	€53k
of which > 1y	€109k
Working capital	€-26k
Employees (FTE)	-

Ratios (computed)

	2024
Current ratio	0.50
Quick ratio	0.50
Working capital ratio	-11.1%
Solvency	30.4%
Debt / equity	2.29
Long-term debt ratio	1.52
Interest coverage	11.54
Gross margin	-
Net margin	-
ROA	13.7%
ROE	45.0%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Balance-sheet composition 2024

Assets

Fixed assets €204k · 88.5% Current assets €27k · 11.5%

Equity & liabilities

Equity €72k · 30.4% Debt €164k · 69.6%

Full annual accounts (24 line items)

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€235k
Fixed assets	21/28	€204k
Formation expenses	20	€5k
Intangible fixed assets	21	€136k
Tangible fixed assets	22/27	€69k
Current assets	29/58	€27k
Amounts receivable within one year	40/41	€13k
Cash & bank	54/58	€13k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€235k
Equity	10/15	€72k
Contributions / capital	10/11	€4k
Reserves	13	€68k
Amounts payable	17/49	€164k
Amounts payable after one year	17	€109k
Amounts payable within one year	42/48	€53k
Trade debts payable within one year	44	€10k
Income statement
Gross operating margin	9900	€71k
Operating result	9901	€47k
Financial income	75	€0
Financial charges	65	€6k
Result before taxes	9903	€41k
Income taxes	67/77	€9k
Net result for the period	9904	€32k
Result to be appropriated	9905	€32k

This table shows the latest fiscal year. 1 prior year, with figures and ratios, belongs to a paid plan. See plans →

Ratios computed by Checked.

Health barometer

FY 2024 · computed

53 / 100 Fair

050100

Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →

Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

on the map · from the address register

exact location from the address register On OpenStreetMap

2 companies at this address See who is registered here

Establishment units

1 location

Dr. Sofie Buyse

Bakboord 25A, 8301 Knokke-HeistActiviteiten van huisartspraktijken

since 20232.342.108.748

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Parcels2

Ground area2,836 m²

Buildings2

Building footprint707 m²

Volume (LiDAR)1,043 m³

Tallest building8.7 m · ±2 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 2 (100%)